Eli Lilly is preparing for a major new phase in the lucrative obesity market. The company’s oral GLP-1 pill, orforglipron, is on track for a potential U.S. launch beginning in the second quarter of ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results